Incruse ellipta: effectiveness, side effects, alternatives in the real world

Summary:

Incruse ellipta: umeclidinium bromide

We study 8,485 Incruse ellipta users. The information eHealthMe analyzes includes:

- Effectiveness of Incruse ellipta
- Alternative drugs to Incruse ellipta
- Incruse ellipta side effects and drug interactions


Number of reports submitted per year:

Incruse ellipta: 8,485 reports from FDA and social media.

Incruse ellipta side effects by duration, gender and age:

Browse all side effects of Incruse ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Incruse ellipta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Do you take Incruse ellipta?

- You can use our AI tools to monitor drug safety and effectiveness.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference. Browse all drugs on eHealthMe.



Recent studies on eHealthMe: